4 days Wall Street Analysts See a 31.3% Upside in Adma Biologics (ADMA): Can the Stock Really Move This High?Zacks

The average of price targets set by Wall Street analysts indicates a potential upside of 31.3% in Adma Biologics (ADMA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street

55 mins Billionaire Ray Dalio Increased Bridgewater’s Stake in Palantir by More Than 500% and Completely Exited His Position in a Premier Media StockThe Motley Fool X

2 hours Nvidia stock gets a rare Wall Street analyst downgradeInvesting.com X

12 hours Gap (GAP) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks X

13 hours Trump’s Wall Street head hunt puts spotlight on ApolloInvesting.com X

14 hours Wall Street closes higher as Dow, S&P hit one-week topsInvesting.com X

14 hours Elon Musk said what a lot of CEOs think: RTO mandates are meant to make you to quitFast Company X

15 hours Investors should look to unloved sectors like utilities, says Wall Street Alliance’s Aadil ZamanYouTube X

15 hours Wall Street turns positive as Dow hits one-week highInvesting.com X

15 hours I’m only 28 but a lucky stock pick has pushed my net worth to over $3 million – should I realistically stop working?24/7 Wall St. X

15 hours Applied Materials (AMAT) Expands EPIC Platform to Accelerate Advanced Chip Packaging and Energy-Efficient ComputingInsider Monkey X

15 hours Netflix Stock Gets Price-Target Hikes As Shares Surge To Record HeightsInvestor's Business Daily X

16 hours Will 2025 Bring Similar Results For S&P 500?: Here’s What Wall Street Is Saying | Forbes ToplineYouTube X

16 hours Piper Sandler highlights the stocks most likely to benefit from bullish market sentimentCNBC X

16 hours ‘Flawless’: Wall Street analysts cheer Nvidia’s latest blowout earnings reportYahoo Finance X

16 hours SEC Chair Gary Gensler resigns, leaves legacy of division and crypto feudsFortune X

17 hours These American Cities Will Leave You Broke Unless You Make at Least $100,00024/7 Wall St. X

17 hours Wall St indexes mixed as Alphabet weighs; Dow hits one-week highInvesting.com X

17 hours SEC Chair Gary Gensler will step down Jan. 20, making way for Trump replacementCNBC X

17 hours Gary Gensler to step down as SEC chair, in a move that has crypto bulls ‘glad’MarketWatch X

17 hours How Oracle Got Its Mojo Back. What’s Behind The AI Cloud Push Powering Its 80% Stock Gain.Investor's Business Daily X

17 hours 14 AI News Updates Wall Street Is MonitoringInsider Monkey X

17 hours I’m 42 with $2.5 million in index funds and we’re not sure how much we spend per year and need help getting organized24/7 Wall St. X

18 hours I’m a high-income earner and I can’t find a partner to match my ambition. Help!24/7 Wall St. X

19 hours 4 Stocks That Have Declared Dividend Hikes Amid Market VolatilityZacks X

20 hours Wall St mixed after Nvidia results; Alphabet weighsInvesting.com X

20 hours Wall Street Analysts Predict a 25.66% Upside in Methanex (MEOH): Here’s What You Should KnowZacks X

20 hours Wall Street Analysts Think Pros Holdings (PRO) Could Surge 34.9%: Read This Before Placing a BetZacks X

20 hours Wall Street Analysts Believe Omnicell (OMCL) Could Rally 26.73%: Here’s is How to TradeZacks X

20 hours Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect?Zacks X

20 hours Wall Street Analysts See a 25.04% Upside in Brookfield Business Partners (BBU): Can the Stock Really Move This High?Zacks X

20 hours Wall Street Analysts Believe Abacus Life, Inc. (ABL) Could Rally 59.48%: Here’s is How to TradeZacks X

20 hours 1 Wall Street Analyst Thinks Tesla Stock Is Going to $400. Is It a Buy?The Motley Fool X

20 hours Down -12.82% in 4 Weeks, Here’s Why Uber (UBER) Looks Ripe for a TurnaroundZacks X

20 hours Down -8.09% in 4 Weeks, Here’s Why Steven Madden (SHOO) Looks Ripe for a TurnaroundZacks X

20 hours ALX Oncology Holdings (ALXO) Loses -27.11% in 4 Weeks, Here’s Why a Trend Reversal May be Around the CornerZacks X

20 hours Lineage Cell (LCTX) Loses -26.3% in 4 Weeks, Here’s Why a Trend Reversal May be Around the CornerZacks X

20 hours Down -23.46% in 4 Weeks, Here’s Why You Should You Buy the Dip in Compass Therapeutics, Inc. (CMPX)Zacks X

20 hours Gladstone Commercial (GOOD) Is Considered a Good Investment by Brokers: Is That True?Zacks X

20 hours Broadwind Energy (BWEN) Is Considered a Good Investment by Brokers: Is That True?Zacks X

20 hours Is It Worth Investing in Analog Devices (ADI) Based on Wall Street’s Bullish Views?Zacks X

20 hours Bit Digital (BTBT) Is Considered a Good Investment by Brokers: Is That True?Zacks X

20 hours Is Monday.com (MNDY) a Buy as Wall Street Analysts Look Optimistic?Zacks X

20 hours Is Aptiv (APTV) a Buy as Wall Street Analysts Look Optimistic?Zacks X

20 hours Wall Street Bulls Look Optimistic About Nvidia (NVDA): Should You Buy?Zacks X

20 hours Brokers Suggest Investing in Amazon (AMZN): Read This Before Placing a BetZacks X

20 hours Wall Street Bulls Look Optimistic About Signet (SIG): Should You Buy?Zacks X

21 hours Wall St set for higher open after jobless claims data, Nvidia resultsInvesting.com X

21 hours Gear Up for Kohl’s (KSS) Q3 Earnings: Wall Street Estimates for Key MetricsZacks X

21 hours Ahead of HP (HPQ) Q4 Earnings: Get Ready With Wall Street Estimates for Key MetricsZacks X

21 hours Insights Into Analog Devices (ADI) Q4: Wall Street Projections for Key MetricsZacks X